Dokunmu Titilope

Contents

  1. College
  2. School
  3. Department
  4. Research Interests
  5. Awards & Honours
  6. Teaching Areas
  7. Selected Publications (29)
  8. Conferences Attended
  9. Summary of Profile
  10. Curriculum Vitae

Dr Titilope Dokunmu

Lecturer

B.Sc., M.Sc., Ph.D

College

College of Science and Technology

School

Departments

Department

Biochemistry

Research Interests

Cancer biology, genomics of diseases, public health, malaria, experimental therapeutics

Awards & Honours

  • National Cancer Institute Fellowship for Molecular Prevention (April, 2019)
  • Global Scholar in Training Award by the American Association for Cancer Research (January, 2019).
  • Global Health Travel Award by the Bill and Melinda Gates Foundation for Keystone Symposia on Vectors, Pathogens and Diseases: Current Trends and Emerging Challenges (T1) (September 10 – 15, 2017).
  • World Bank African Centre of Excellence Fellowship for Genomics of Infectious Diseases training at Organismic Biology Department, Harvard University, Cambridge, MA, USA (June – August, 2014).
  • Global Health Travel Award by the Bill and Melinda Gates foundation for Keystone Symposia on Malaria Innovation and Eradication (February 2 – 7, 2014).

Teaching Areas

  • Clinical biochemistry
  • Pharmacology
  • Molecular Biology
  • Bioinformatics

Selected Publications (29)

1. Dataset on analysis of quality of health and social insurance subscription in different socio-economic class of workers in selected areas in southwest Nigeria

[Visit]

2. Protective Effects of Caffeine and Artemisinin against Initiation of Breast Tumour in 7, 12-Dimethylbenzanthracene treated Albino Rats

[ Download 780.66 kB ]

3. Hidden in plain sight: The effects of BCG vaccination in COVID-19 pandemic

[Visit]

4. New Insights into the Link between Melanoma and Thyroid Cancer: Role of Nucleocytoplasmic Trafficking

[ Download 683.21 kB ] [Visit]

5. Asymptomatic malaria infections and Pfmdr1 mutations in an endemic area of Nigeria

[ Download 1.38 MB ] [Visit]

6. A review on healthcare schemes in Nigeria: A case of Corona Virus pandemic

[ Download 1.06 MB ]

7. Hepatoprotective Potential and Histological Studies of Effects of Celosia Argentea L. on Paracetamol-Induced Liver Damage

[Visit]

8. Frequencies of Plasmodium falciparum gene mutations in asymptomatic infection: Evaluating malaria transmission reduction in an endemic area

[Visit]

9. Efficiency of histidine rich protein II-based rapid diagnostic tests for monitoring malaria transmission intensities in an endemic area

[Visit]

10. Plasmodium falciparum hyperparasitaemia in Nigerian children: epidemiology, clinical characteristics, and therapeutic responses to oral artemisinin-based combination treatments

[Visit]

11. Cardiovascular Risk Factors in a Suburban Community in Nigeria

[ Download 1.65 MB ] [Visit]

12. Artemisinin-induced delayed hemolysis after administration of artesunate and artesunate-amodiaquine in malaria-free Wistar rats

[ Download 648.02 kB ] [Visit]

13. Ex-vivo response of Plasmodium falciparum to dihydroartemisinin in an area of Ota South-west Nigeria

[Visit]

14. Therapeutic Efficacy and Effects of Artesunate-Mefloquine and Mefloquine Alone on Malaria-Associated Anemia in Children with Uncomplicated Plasmodium falciparum Malaria in Southwest Nigeria

[ Download 503.67 kB ]

15. Effects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children

[ Download 264.93 kB ]

16. Early variations in Plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance

[ Download 615.81 kB ]

17. Plasmodium falciparum gametocyte carriage, emergence, clearance and population sex ratios in anaemic and non-anaemic malarious children

[ Download 481.11 kB ]

18. Plasmodium falciparum gametocyte carriage, sex ratios and asexual parasite rates in Nigerian children before and after a treatment protocol policy change instituting the use of artemisinin-based combination therapies

[ Download 460.27 kB ]

19. Therapeutic Efficacy and Effects of Artemether-lumefantrine and Artesunate-amodiaquine Coformulated or Copackaged on Malaria-Associated Anemia in Children with Uncomplicated Plasmodium falciparum Malaria in Southwest Nigeria

[ Download 684.61 kB ]

20. Risk factors for Plasmodium falciparum hyperparasitaemia in malarious children

[ Download 238.23 kB ]

21. Therapeutic Efficacies of Artemisinin-Based Combination Therapies in Nigerian Children with Uncomplicated Falciparum Malaria during Five Years of Adoption as First-Line Treatments

[ Download 644.75 kB ]

22. Use of area under the curve to evaluate the effects of antimalarial drugs on malaria associated anemia after treatment

[ Download 462.75 kB ]

23. A Simple Dose Regimen of Artesunate and Amodiaquine Based on Arm Span- or Age Range for Childhood Falciparum Malaria: A Preliminary Evaluation

[ Download 154.44 kB ]

24. Oral Artesunate–Amodiaquine and Artemether–Lumefantrine in the Treatment of Uncomplicated Hyperparasitaemic Plasmodium falciparum Malaria in Children

[ Download 94.68 kB ]

25. Fall in Hematocrit per 1000 Parasites Cleared From Peripheral Blood: A Simple Method for Estimating Drug-Related Fall in Hematocrit After Treatment of Malaria Infections

[Visit]

26. Efficacy of Artemisinin-Based Combination Treatments of Uncomplicated Falciparum Malaria in Under-Five-Year-Old Nigerian Children

[Visit]

27. Factors contributing to delay in parasite clearance in uncomplicated falciparum malaria in children

[ Download 779.27 kB ]

28. Recrudescent Plasmodium falciparum infections in children in an endemic area following artemisinin-based combination treatments: Implications for disease control

[ Download 358.64 kB ]

29. Early Changes in Plasmodium falciparum Asexual and Sexual Populations in Children with Acute Infections Following Treatment with Artemisinin-Based Combination Drugs

[ Download 683.08 kB ]

Conferences Attended

Annual conference of American Association for Cancer Research held on March 29-April 3, 2019 at Atlanta, Georgia, USA.
93rd Louisiana Academy of Sciences Conference held on March 16, 2019 at Southern University, Baton Rouge, LA, USA.
5th Biennial Science of Global Prostate Cancer Conference in Black Men, held on 7 – 10 November, 2018 at University of Ilorin, Nigeria.
1st International Women Multidisciplinary Conference on advancing women in academia and industry: strategies, policies, and emerging issues in the 21st century held on September 11-12, 2018 at Africa Leadership Development Centre, Covenant University, Nigeria.
Experimental Biology-American Society of Pharmacology and Experimental Therapeutics (Molecular pharmacology) conference, San Diego, USA (April 21-25, 2018).
Keystone Symposia on Vectors, pathogens and current challenges conference, Durban, South Africa (Sept 10 – 14, 2017).

Summary of Profile

Titilope Dokunmu is a researcher in the Department of Biochemistry, where she teaches basic biomedical sciences, biochemistry, molecular biology and pharmacology. She is a multidisciplinary scientist with expertise in biochemistry, cell culture, molecular biology, genomics and experimental therapeutics. Her research focus is on disease mechanisms and dynamics. Her research interest is on molecular
epidemiology and dynamics of infectious diseases and cancer biology, pharmacological compounds and resistance to chemotherapeutic drugs. She has
worked in the fields of breast, melanoma and thyroid cancer, and infectious diseases including malaria and Corona virus. Dr. Dokunmu is passionate about teaching, research, mentoring, and health education. Her goal is to teach and simplify learning and to engage in research that reduces public health burdens. She aims to be a successful global scientist that impacts society positively in the area of public health and education.

Curriculum Vitae

Dokunmu CV- CU.pdf 504.57 kB
 
 
Last Updated:

09/11/2020 10:54 am